Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Alvogen
Alvogen
Activities:
Regulatory
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Finance
Alvogen partners with Kinaxis on supply chain management
Kinaxis will help Alvogen effectively manage its product introduction and tender processes to determine project feasibility and impact across the supply chain
Distribution
Dipharma and Alvogen launch Diterin in South Korea
First drug commercially available for the treatment of hyperphenylalaninemia due to phenylketonuria
Finance
CVC Capital Partners leads consortium to acquire controlling stake in Alvogen
Consortium will provide funds to help Alvogen become a leading generics player worldwide
Finance
Alvogen acquires Dream Pharma of Korea for US$187m
Third significant acquisition for the company in the Asia-Pacific region since 2012
Manufacturing
Alvotech invests US$250m in biopharmaceuticals
Portfolio of biosimilar products to be marketed by sister company, Alvogen
Ingredients
Alvogen expands its operations in India
Clinical service and API sourcing capabilities established
Subscribe now